| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/JID.2008.425 |
| P8608 | Fatcat ID | release_wzh7pti7ifeyveg2ledkfcxleu |
| P698 | PubMed publication ID | 19369934 |
| P5875 | ResearchGate publication ID | 24280986 |
| P50 | author | Ralf Paus | Q37381598 |
| P2093 | author name string | Matthew J Harries | |
| P2860 | cites work | How not to get scar(r)ed: pointers to the correct diagnosis in patients with suspected primary cicatricial alopecia. | Q37381748 |
| Placebo response in two long-term randomized psoriasis studies that were negative for rosiglitazone | Q40224318 | ||
| Early cutaneous gene transcription changes in adult atopic dermatitis and potential clinical implications | Q40258455 | ||
| Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma | Q42459998 | ||
| Apoptosis in different cutaneous manifestations of lupus erythematosus | Q42504565 | ||
| Investigational methods for peroxisomal disorders | Q46478829 | ||
| Scarring skin lesions of discoid lupus erythematosus are characterized by high numbers of skin-homing cytotoxic lymphocytes associated with strong expression of the type I interferon-induced protein MxA. | Q46753315 | ||
| Scd1 is expressed in sebaceous glands and is disrupted in the asebia mouse. | Q52536865 | ||
| [Scar forming alopecia. Comments on classification, differential diagnosis and pathobiology] | Q52994126 | ||
| Detection of Type 1 Cytokines in Discoid Lupus Erythematosus | Q54165706 | ||
| Possible role of the bulge region in the pathogenesis of inflammatory scarring alopecia: lichen planopilaris as the prototype | Q61446974 | ||
| Involvement of the bulge region in primary scarring alopecia | Q62067966 | ||
| Update on cicatricial alopecia | Q73743429 | ||
| Clusters of perifollicular macrophages in normal murine skin: physiological degeneration of selected hair follicles by programmed organ deletion | Q74258245 | ||
| Evaluation of inflammatory infiltrate and fibrogenic cytokines in pseudopelade of Brocq suggests the involvement of T-helper 2 and 3 cytokines | Q80373673 | ||
| Peroxisome proliferators induce mouse liver stearoyl-CoA desaturase 1 gene expression | Q28379103 | ||
| Insights from the asebia mouse: a molecular sebaceous gland defect leading to cicatricial alopecia | Q34366156 | ||
| Stem cells in the hair follicle bulge contribute to wound repair but not to homeostasis of the epidermis | Q34467701 | ||
| Epithelial stem cells: a folliculocentric view | Q34538889 | ||
| Hair follicle stem cell-specific PPARgamma deletion causes scarring alopecia | Q35089001 | ||
| CD200, a "no danger" signal for hair follicles | Q36357348 | ||
| Peroxisome proliferator-activated receptors (PPARs) in skin health, repair and disease | Q36776473 | ||
| PPARgamma in immunity and inflammation: cell types and diseases. | Q36785477 | ||
| Peroxisome proliferator-activated receptors (PPARs) and the human skin: importance of PPARs in skin physiology and dermatologic diseases | Q37037626 | ||
| Thematic review series: skin lipids. Peroxisome proliferator-activated receptors and liver X receptors in epidermal biology. | Q37053367 | ||
| Management of primary cicatricial alopecias: options for treatment. | Q37167668 | ||
| PPARgamma agonists as therapeutics for the treatment of Alzheimer's disease | Q37215869 | ||
| Integration of metabolism and inflammation by lipid-activated nuclear receptors | Q37225357 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1066-1070 | |
| P577 | publication date | 2009-05-01 | |
| P1433 | published in | Journal of Investigative Dermatology | Q3186921 |
| P1476 | title | Scarring alopecia and the PPAR-gamma connection | |
| P478 | volume | 129 |
| Q42501734 | Abnormal sebaceous gland differentiation in 10 kittens ('sebaceous gland dysplasia') associated with generalized hypotrichosis and scaling |
| Q52585551 | CME Part 2: Hair disorders in cancer survivors Persistent chemotherapy-induced alopecia, persistent radiotherapy-induced alopecia, and hair growth disorders related to endocrine therapy or cancer surgery. |
| Q38001797 | Cicatricial (scarring) alopecias: an overview of pathogenesis, classification, diagnosis, and treatment. |
| Q37540435 | DHEA and frontal fibrosing alopecia: molecular and physiopathological mechanisms |
| Q33813533 | Deciphering the mesodermal potency of porcine skin-derived progenitors (SKP) by microarray analysis. |
| Q59384354 | Delineating Immune-Mediated Mechanisms Underlying Hair Follicle Destruction in the Mouse Mutant Defolliculated |
| Q34779918 | Lichen planopilaris is characterized by immune privilege collapse of the hair follicle's epithelial stem cell niche |
| Q34409844 | Long-term bezafibrate treatment improves skin and spleen phenotypes of the mtDNA mutator mouse |
| Q37601567 | Mouse model phenotypes provide information about human drug targets |
| Q48247479 | PPAR-γ Agonists and Their Role in Primary Cicatricial Alopecia. |
| Q91729705 | Pathomechanisms of immune-mediated alopecia |
| Q38341507 | The role of PPARγ-mediated signalling in skin biology and pathology: new targets and opportunities for clinical dermatology |
| Q52674368 | [Frontal fibrosing alopecia]. |
Search more.